Skip to the page

Data / Drug companies / Beyond Health P.A.

Beyond Health P.A.: 9 products in the FDA NDC directory, labeler code 70942

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Beyond Health P.A. (labeler code 70942) lists 9 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 9 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on July 22, 2025.

The request: Watch Beyond Health P.A. (FDA labeler code 70942): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
70942
Products in commercial distribution
9
Packages
15
Finished drugs by generic name
9
Prescription products
0
Over the counter products
9
Flagged as original packager
7 of 7 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
July 26, 2021
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs9100%

Products by type

TypeProductsShare
Over the counter drugs9100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Phenylephrine hydrochloride 0.25%, witch hazel 50%11
Witch hazel 50%11
Petrolatum 36%11
Glycerin 37.5%, lanolin 12.5%, lidocaine 4%, zinc oxide 5%11
Mineral oil 59.8%,petrolatum 36%11
Lidocaine hcl 5%, phenylephrine hcl 0.25%, witch hazel 50%11
Lidocaine 5%123
Mineral oil 59.8%, petrolatum 36.0%11
Lidocaine 4.00, phenylephrine hydrochloride 0.2511

Dosage forms

Dosage formProductsShare
Spray555.6%
Ointment222.2%
Swab111.1%
Cream111.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Dr Butlers Soothing Incontinence70942-200SprayOver the counter monograph drugsJuly 22, 2025
Dr Butlers Advanced Hemorrhoid Relief70942-127SprayOver the counter monograph drugsJuly 22, 2024
Dr Butlers Hemorrhoid70942-100SwabOver the counter monograph drugsJuly 22, 2024
Dr Butlers Hemorrhoid and Fissure PF70942-357OintmentOver the counter monograph drugsFebruary 20, 2023
Doctor Butlers Hemorrhoid and Fissure External Pain Formula70942-121CreamOver the counter monograph drugsMarch 1, 2022
Dr. Butler Hemorrhoid Treatment70942-135SprayOver the counter monograph drugsDecember 10, 2021
Doctor Butler Hemorrhoid and Fissure Advanced Formula70942-517OintmentOver the counter monograph drugsSeptember 20, 2021
Dr. Butler Hemorrhoid and Perineal70942-117SprayOver the counter monograph drugsJuly 26, 2021
Dr. Butler Soothing Incontinence70942-017SprayOver the counter monograph drugsJuly 26, 2021

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.